| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Bajaj Finserv Healthcare Fund Reg (G) |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
4.50 |
| Equity |
95.50 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
33.50% |
| Top 10 Holdings |
50.16% |
| Top 25 Holdings |
82.06% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
66.29 |
| Healthcare |
17.21 |
| Cash |
4.5 |
| Food Beverage & Tobacco |
2.69 |
| FMCG |
1.58 |
| Industrial Products |
1.56 |
| Personal Products |
1.37 |
| Miscellaneous |
1.35 |
| Retail |
1.34 |
| Agricultural & Farm Machinery |
1.18 |
| Chemicals |
0.49 |
| Finance & Investments |
0.44 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.62 |
| PE Ratio |
43.15 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| DIVI LABORATORIES LTD |
8.71 |
| Sun Pharmaceutical Industries Limited |
7.82 |
| Cipla Limited |
6.61 |
| Apollo Hospitals Enterprise Limited |
5.86 |
| Net Receivables / (Payables) |
4.50 |
| Dr Reddys Laboratories Limited |
3.52 |
| Piramal Pharma Limited |
3.50 |
| Biocon Limited |
3.43 |
| Emcure Pharmaceuticals Limited |
3.40 |
| Glenmark Pharmaceuticals Limited |
2.81 |
| Neuland Laboratories Limited |
2.76 |
| Syngene International Limited |
2.65 |
| Glaxosmithkline Pharma Ltd |
2.63 |
| Torrent Pharmaceuticals Limited |
2.42 |
| Abbott India Limited |
2.33 |
| Pfizer Limited |
2.24 |
| IPCA Laboratories Limited |
2.24 |
| SANOFI CONSUMER HEALTHCARE |
2.08 |
| Rainbow Childrens Medicare Limited |
2.01 |
| Zydus Wellness Limited |
1.94 |
| Dr Lal Path Labs Ltd |
1.90 |
| Vijaya Diagnostic Centre Limited |
1.84 |
| Fortis Health Care Ltd |
1.72 |
| Hindustan Unilever Limited |
1.58 |
| Shaily Engineering Plastics Limited |
1.56 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
